Charlsonkomorbiditási

Charlsonkomorbiditási, or the Charlson Comorbidity Index, is a weighted index used to predict the one-year mortality risk of a patient. It was developed by Dr. Mary Charlson and colleagues in 1987. The index assigns a score based on the presence of specific comorbid conditions, each with a weighted value. These conditions range from less severe issues like obesity to more life-threatening ones such as acquired immune deficiency syndrome (AIDS).

The Charlson Comorbidity Index is widely used in clinical practice and research to account for the impact of comorbidities on patient outcomes. It helps clinicians understand a patient's overall health status beyond their primary diagnosis, which can be crucial for treatment planning, resource allocation, and prognostic assessments. A higher score on the index indicates a greater likelihood of mortality.

The index is calculated by summing the scores of the various comorbid conditions a patient has. For example, myocardial infarction is assigned a score of 1, while metastasis from cancer receives a score of 6. The total score is then used to estimate the probability of the patient surviving for one year. Its simplicity and ability to capture the cumulative burden of disease make it a valuable tool in healthcare settings worldwide.

---